GALAD SCORE IS USEFUL FOR RISK STRATIFICATION OF HCC DEVELOPMENT IN PATIENTS WITH LI-RADS 3 OR 4 LESIONS

被引：0
|
作者：
Liang, Jeff [1 ]
Yeo, Yee Hui [1 ]
Noureddin, Mazen [2 ]
Ayoub, Walid S. [3 ]
Kuo, Alexander [4 ]
Sundaram, Vinay [5 ,6 ]
Todo, Tsuyoshi [7 ]
Kim, Irene [5 ]
Voidonikolas, Georgios [8 ]
Brennan, Todd V. [7 ]
Wisel, Steven [5 ]
Kosari, Kambiz [9 ]
Saouaf, Rola [10 ]
Nissen, Nicholas [7 ]
Yang, Ju Dong [7 ,11 ,12 ]
机构：
[1] Cedars Sinai Med Ctr, Div Gen Internal Med, Los Angeles, CA USA
[2] Cedars Sinai Med Ctr, Div Digest & Liver Dis, Comprehens Transplant Ctr, Los Angeles, CA USA
[3] Cedars Sinai, Los Angeles, CA USA
[4] Cedars Sinai Med Ctr, Los Angeles, CA USA
[5] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA USA
[6] Cedars Sinai Med Ctr, Gastroenterol, Los Angeles, CA USA
[7] Cedars Sinai Med Ctr, Comprehens Transplant Ctr, Los Angeles, CA USA
[8] Cedar Sinai Med Ctr, Los Angeles, CA USA
[9] Cedars Sinai Med Ctr, Gen Surg, Los Angeles, CA USA
[10] Cedars Sinai Med Ctr, Imaging, Los Angeles, CA USA
[11] Cedars Sinai Med Ctr, Karsh Div Gastroenterol & Hepatol, Los Angeles, CA USA
[12] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA USA
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4567
引用
收藏
页码：S1432 / S1433
页数：2
相关论文
共 50 条
  • [21] GALAD score is effective for HCC surveillance among high-risk patients
    Hirode, Grishma
    Zangneh, Hooman Farhang
    Cerocchi, Orlando
    El-Karim, Lima Awad
    Khalili, Korosh
    Janssen, Harry L. A.
    Hansen, Bettina E.
    Feld, Jordan J.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S49 - S49
  • [22] RISK OF PROGRESSION TO HEPATOCELLULAR CARCINOMA IN PATIENTS WITH INDETERMINATE (LI-RADS 3) LIVER OBSERVATIONS
    Arvind, Ashwini
    Joshi, Sagar
    Zaki, Timothy
    Burkholder, Daniel A.
    Yokoo, Takeshi
    Fetzer, David
    Browning, Travis
    Rich, Nicole E.
    Marrero, Jorge A.
    Yopp, Adam C.
    Gopal, Purva
    Parikh, Neehar D.
    Singal, Amit G.
    HEPATOLOGY, 2021, 74 : 668A - 669A
  • [23] Expanding the Liver Imaging Reporting and Data System (LI-RADS) v2018 diagnostic population: performance and reliability of LI-RADS for distinguishing hepatocellular carcinoma (HCC) from non-HCC primary liver carcinoma in patients who do not meet strict LI-RADS high-risk criteria
    Ludwig, Daniel R.
    Fraum, Tyler J.
    Cannella, Roberto
    Tsai, Richard
    Naeem, Muhammad
    LeBlanc, Maverick
    Salter, Amber
    Tsung, Allan
    Fleckenstein, Jaquelyn
    Shetty, Anup S.
    Borhani, Amir A.
    Furlan, Alessandro
    Fowler, Kathryn J.
    HPB, 2019, 21 (12) : 1697 - 1706
  • [24] Clinical Outcomes of Patients With Suspicious (LI-RADS 4) Liver Observations
    Onyirioha, Kristeen
    Joshi, Sagar
    Burkholder, Daniel
    Yekkaluri, Sruthi
    Parikh, Neehar D.
    Singal, Amit G.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (06) : 1649 - 1651
  • [25] Risk Stratification and Distribution of Hepatocellular Carcinomas in CEUS and CT/MRI LI-RADS: A Meta-Analysis
    Zhou, Yan
    Qin, Zhengyi
    Ding, Jianmin
    Zhao, Lin
    Chen, Ying
    Wang, Fengmei
    Jing, Xiang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [26] VALUE OF CONTRAST-ENHANCED ULTRASOUND LI-RADS 2017 IN PATIENTS AT HIGH RISK OF HEPATOCELLULAR CARCINOMA: A COMPARISON STUDY WITH CT/MRI LI-RADS
    Ding, Jianmin
    Zhou, Yan
    Jing, Xiang
    HEPATOLOGY, 2020, 72 : 687A - 687A
  • [27] A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions
    Min, Ji Hye
    Kim, Jong Man
    Kim, Young Kon
    Kim, Honsoul
    Choi, Gyu Seong
    Kang, Tae Wook
    Cha, Dongik
    Hwang, Jeong Ah
    Ko, Seong Eun
    Ahn, Soohyun
    EUROPEAN RADIOLOGY, 2022, 32 (02) : 912 - 922
  • [28] A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions
    Ji Hye Min
    Jong Man Kim
    Young Kon Kim
    Honsoul Kim
    Gyu Seong Choi
    Tae Wook Kang
    Dongik Cha
    Jeong Ah Hwang
    Seong Eun Ko
    Soohyun Ahn
    European Radiology, 2022, 32 : 912 - 922
  • [29] Clinical predictors of progression of a hepatic lesion from Li-RADS (LR) 3 to LR5 among patients (pts) at risk of hepatocellular carcinoma (HCC)
    Hannan, Lindsay Marie
    Harris, William Proctor
    Ojeda, Patricia I.
    Park, James O.
    Mieloszyk, Rebecca
    Bhargava, Puneet
    Johnson, Guy E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [30] Optimizing LI-RADS: ancillary features screened from LR-3/4 categories can improve the diagnosis of HCC on MRI
    Zhang, Zi-xin
    Xv, Hui
    Du, Yan-ni
    Lv, Zhi-bin
    Yang, Zheng-han
    BMC GASTROENTEROLOGY, 2024, 24 (01)
12345